Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
| dc.contributor.author | Chan, Arlene | |
| dc.contributor.author | McGregor, S. | |
| dc.date.accessioned | 2017-03-15T22:02:00Z | |
| dc.date.available | 2017-03-15T22:02:00Z | |
| dc.date.created | 2017-02-24T00:09:07Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | Chan, A. and McGregor, S. 2012. Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab. Internal Medicine Journal. 42 (3): pp. 267-274. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/49060 | |
| dc.publisher | Blackwell Publishing | |
| dc.title | Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab | |
| dc.type | Journal Article | |
| dcterms.source.volume | 42 | |
| dcterms.source.number | 3 | |
| dcterms.source.startPage | 267 | |
| dcterms.source.endPage | 274 | |
| dcterms.source.issn | 14440903 | |
| dcterms.source.title | Internal Medicine Journal | |
| curtin.department | Mount Hospital | |
| curtin.accessStatus | Fulltext not available |